Drug name - Tekturna Hct

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8618172 NODEN PHARMA Galenical formulations of organic compounds Jul, 2028

(5 years from now)

More Information on Dosage
Strength Dosage Availability
EQ 150MG BASE;12.5MG TABLET;ORAL Discontinued
EQ 150MG BASE;25MG TABLET;ORAL Discontinued
EQ 300MG BASE;12.5MG TABLET;ORAL Prescription
EQ 300MG BASE;25MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.